The Long-Term Effectiveness and Safety of Cannabidiol-Enriched Oil in Children With Drug-Resistant Epilepsy

被引：4
作者：
Tzadok, Michal [1 ,2 ,3 ]
Hamed, Nasrin [1 ,2 ]
Heimer, Gali [1 ,2 ]
Zohar-Dayan, Efrat [1 ,2 ]
Rabinowicz, Shira [1 ,2 ]
Ben Zeev, Bruria [1 ,2 ]
机构：
[1] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Pediat Neurol Unit, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[3] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Pediat Neurol Unit, IL-5262000 Ramat Gan, Israel
来源：
PEDIATRIC NEUROLOGY | 2022年 / 136卷
关键词：
Cannabidiol; Artisanal cannabis oil; Refractory epilepsy; Seizures; Long-term follow-up; PEDIATRIC EPILEPSY; ANTICONVULSANT; SEIZURES; EXTRACTS; CANNABINOIDS; MODELS; TRIAL; MOUSE;
D O I：
10.1016/j.pediatrneurol.2022.06.016
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Background: Several retrospective studies on pediatric epilepsy reported positive effects of cannabidiol-enriched artisanal cannabis oil and pure cannabidiol oil on seizure reduction. Methods: This is a retrospective study of children and adolescents with refractory epilepsy caused by various etiologies who were treated with artisanal cannabis oil during January 2014 to June 2019, with at least one year follow-up. Results: Of 114 patients, 84 (73.3%) reported some improvement in seizure frequency at some point during treatment. Fifty-one (59%) of the 86 patients who continued treatment for at least one year showed >50% improvement in seizure frequency. Seizure etiology, seizure type, and patients' age and sex were not found to be associated with the response to cannabidiol-enriched cannabis oil. Side effects were minor, and positive effects beyond seizure reduction were noted. Conclusions: Artisanal cannabidiol-enriched cannabis may be an effective and safe long-term treatment for refractory epilepsy. (c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码：15 / 19
页数：5
相关论文
共 30 条
  • [1] Epilepsy and cannabidiol: a guide to treatment
    Arzimanoglou, Alexis
    Brandi, Ulrich
    Cross, J. Helen
    Gil-Nagel, Antonio
    Lagae, Lieven
    Landmark, Cecilie Johannessen
    Specchio, Nicola
    Nabbout, Rima
    Thiele, Elizabeth A.
    Gubbay, Oliver
    [J]. EPILEPTIC DISORDERS, 2020, 22 (01) : 1 - 14
  • [2] Molecular Targets of Cannabidiol in Neurological Disorders
    Bih, Clementino Ibeas
    Chen, Tong
    Nunn, Alistair V. W.
    Bazelot, Michael
    Dallas, Mark
    Whalley, Benjamin J.
    [J]. NEUROTHERAPEUTICS, 2015, 12 (04) : 699 - 730
  • [3] Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
    Devinsky, Orrin
    Patel, Anup D.
    Thiele, Elizabeth A.
    Wong, Matthew H.
    Appleton, Richard
    Harden, Cynthia L.
    Greenwood, Sam
    Morrison, Gilmour
    Sommerville, Kenneth
    [J]. NEUROLOGY, 2018, 90 (14) : E1204 - +
  • [4] Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
    Devinsky, Orrin
    Patel, Anup D.
    Cross, J. Helen
    Villanueva, Vicente
    Wirrell, Elaine C.
    Privitera, Michael
    Greenwood, Sam M.
    Roberts, Claire
    Checketts, Daniel
    VanLandingham, Kevan E.
    Zuberi, Sameer M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20) : 1888 - 1897
  • [5] Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
    Devinsky, Orrin
    Cross, J. Helen
    Laux, Linda
    Marsh, Eric
    Miller, Ian
    Nabbout, Rima
    Scheffer, Ingrid E.
    Thiele, Elizabeth A.
    Wright, Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (21) : 2011 - 2020
  • [6] Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
    Devinsky, Orrin
    Marsh, Eric
    Friedman, Daniel
    Thiele, Elizabeth
    Laux, Linda
    Sullivan, Joseph
    Miller, Ian
    Flamini, Robert
    Wilfong, Angus
    Filloux, Francis
    Wong, Matthew
    Tilton, Nicole
    Bruno, Patricia
    Bluvstein, Judith
    Hedlund, Julie
    Kamens, Rebecca
    Maclean, Jane
    Nangia, Srishti
    Singhal, Nilika Shah
    Wilson, Carey A.
    Patel, Anup
    Cilio, Maria Roberta
    [J]. LANCET NEUROLOGY, 2016, 15 (03) : 270 - 278
  • [7] Phytocannabinoids and epilepsy
    dos Santos, R. G.
    Hallak, J. E. C.
    Leite, J. P.
    Zuardi, A. W.
    Crippa, J. A. S.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (02) : 135 - 143
  • [8] Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
    Englund, Amir
    Morrison, Paul D.
    Nottage, Judith
    Hague, Dominic
    Kane, Fergus
    Bonaccorso, Stefania
    Stone, James M.
    Reichenberg, Avi
    Brenneisen, Rudolf
    Holt, David
    Feilding, Amanda
    Walker, Lucy
    Murray, Robin M.
    Kapur, Shitij
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (01) : 19 - 27
  • [9] Cannabinoids in the Treatment of Epilepsy
    Friedman, Daniel
    Devinsky, Orrin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11) : 1048 - 1058
  • [10] Cannabidivarin is anticonvulsant in mouse and rat
    Hill, A. J.
    Mercier, M. S.
    Hill, T. D. M.
    Glyn, S. E.
    Jones, N. A.
    Yamasaki, Y.
    Futamura, T.
    Duncan, M.
    Stott, C. G.
    Stephens, G. J.
    Williams, C. M.
    Whalley, B. J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (08) : 1629 - 1642
123